Xvivo Perfusion
179.10 SEK
-0.56 %
Less than 1K followers
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xvivo Perfusion
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 198.5 | 227.6 | 822.4 | 218.6 | 178.3 | 189.1 | 226.1 | 812.2 |
| EBITDA | 37.1 | 51.9 | 176.1 | 43.0 | 23.6 | 35.9 | 56.1 | 158.6 |
| EBIT | 20.5 | 15.5 | 88.4 | 26.6 | 7.1 | 17.9 | 36.8 | 88.4 |
| EBIT-% | 10.3 % | 6.8 % | 10.7 % | 12.2 % | 4.0 % | 9.5 % | 16.3 % | 10.9 % |
| Profit before taxes | 87.7 | 49.6 | 200.0 | -14.1 | -3.3 | 14.8 | 41.2 | 38.6 |
| Net income | 85.8 | 36.4 | 172.2 | -12.4 | 1.6 | 4.3 | 31.7 | 25.2 |